table of content
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Anti-cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Anti-cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Anti-cancer Drug Overall Market Size
2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size: 2021 VS 2028
2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.2 Top Global Small Molecule Targeted Anti-cancer Drug Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Anti-cancer Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Molecule Targeted Anti-cancer Drug Market Size Markets, 2021 & 2028
4.1.2 EGFR
4.1.3 ALK
4.1.4 Bcr-Abl
4.1.5 Others
4.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
4.2.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
4.2.3 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2021 & 2028
5.1.2 Liver Cancer
5.1.3 Colorectal Cancer
5.1.4 Lung Cancer
5.1.5 Gastric Cancer
5.1.6 Breast Cancer
5.1.7 Esophageal Cancer
5.1.8 Others
5.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
5.2.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
5.2.3 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2021 & 2028
6.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2022
6.2.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2023-2028
6.2.3 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.3.2 US Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.3.3 Canada Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.3.4 Mexico Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.4.2 Germany Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.3 France Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.4 U.K. Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.5 Italy Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.6 Russia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.7 Nordic Countries Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.4.8 Benelux Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.5.2 China Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.3 Japan Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.4 South Korea Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.5 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.5.6 India Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.6.2 Brazil Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.6.3 Argentina Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, 2017-2028
6.7.2 Turkey Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.3 Israel Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
6.7.5 UAE Small Molecule Targeted Anti-cancer Drug Market Size, 2017-2028
7 Players Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Corporate Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.1.4 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.1.5 Astrazeneca Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.2.4 Novartis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Millennium Pharmaceuticals
7.3.1 Millennium Pharmaceuticals Corporate Summary
7.3.2 Millennium Pharmaceuticals Business Overview
7.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.3.4 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.3.5 Millennium Pharmaceuticals Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.4.4 Bayer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.4.5 Bayer Key News
7.5 Exelixis
7.5.1 Exelixis Corporate Summary
7.5.2 Exelixis Business Overview
7.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.5.4 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.5.5 Exelixis Key News
7.6 Abbvie
7.6.1 Abbvie Corporate Summary
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.6.4 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.6.5 Abbvie Key News
7.7 Boehringer-Ingelheim
7.7.1 Boehringer-Ingelheim Corporate Summary
7.7.2 Boehringer-Ingelheim Business Overview
7.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.7.4 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.7.5 Boehringer-Ingelheim Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.8.4 Eisai Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.9.4 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporate Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.10.4 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.10.5 Bristol-Myers Squibb Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Business Overview
7.11.3 Roche Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.11.4 Roche Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.11.5 Roche Key News
7.12 Bettapharma
7.12.1 Bettapharma Corporate Summary
7.12.2 Bettapharma Business Overview
7.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.12.4 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2017-2022)
7.12.5 Bettapharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
